Cargando…
PIASy antagonizes Ras-driven NSCLC survival by promoting GATA2 SUMOylation
GATA2 regulated transcriptional network has been validated requisite for RAS oncogene-driven non-small cell lung cancer (NSCLC). GATA2 has been reported as a SUMOylated protein. In endothelial cells, its transcriptional activity is attenuated by SUMO-2 conjugation, which is specifically catalyzed by...
Autores principales: | Chen, Bin, Luo, Jie, Zhou, Yirui, Xin, Xu, Cai, Rong, Ling, Chunhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950599/ https://www.ncbi.nlm.nih.gov/pubmed/29760808 http://dx.doi.org/10.7150/jca.24137 |
Ejemplares similares
-
PIASy-dependent SUMOylation regulates DNA topoisomerase IIα activity
por: Ryu, Hyunju, et al.
Publicado: (2010) -
Perturbation of maternal PIASy abundance disrupts zygotic genome activation and embryonic development via SUMOylation pathway
por: Higuchi, Chika, et al.
Publicado: (2019) -
Downregulation of cardiac PIASy inhibits Cx43 SUMOylation and ameliorates ventricular arrhythmias in a rat model of myocardial ischemia/reperfusion injury
por: Wang, Tingting, et al.
Publicado: (2023) -
Homeoprotein Msx1-PIASy Interaction Inhibits Angiogenesis
por: Son, Myung Jin, et al.
Publicado: (2020) -
RAS GTPases are modified by SUMOylation
por: Choi, Byeong Hyeok, et al.
Publicado: (2017)